Home > Boards > US Listed > Biotechs > Applied DNA Sciences Inc. (APDN)

Really, this has all gone on too long.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Parkmart Member Profile
 
Followed By 2
Posts 2,052
Boards Moderated 0
Alias Born 12/19/16
160x600 placeholder
Applied DNA Schedules Fiscal 2019 Fourth Quarter Financial Results Conference Call for Thursday, December 12, 2019 at 4:30 PM... Business Wire - 12/5/2019 5:00:00 AM
 Applied DNA Sciences Subsidiary LineaRx Signs Agreement with TYME Technologies for Functional Invasive Circulating Tumor Ce... Business Wire - 11/26/2019 12:30:00 PM
Applied DNA Sciences Regains Compliance with Nasdaq Listing Standards Business Wire - 11/25/2019 1:17:00 PM
Applied DNA Sciences Reports 14 Development Customers for its Linear DNA Manufacturing Platform Business Wire - 11/25/2019 9:15:00 AM
Applied DNA Sciences Announces Closing of Upsized $12.0 Million Underwritten Public Offering Business Wire - 11/15/2019 12:08:00 PM
Applied DNA Sciences Announces Pricing of Upsized $12.0 Million Underwritten Public Offering Business Wire - 11/13/2019 9:20:00 AM
Registration of Additional Securities (up to 20%) (s-1mef) Edgar (US Regulatory) - 11/13/2019 9:13:26 AM
Successful DNA Tagging of Leather at One of the World’s Largest Tanneries Business Wire - 11/12/2019 9:03:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/8/2019 4:17:47 PM
Applied DNA Sciences Announces Appointment of Scott L. Anchin to Board of Directors  Business Wire - 11/8/2019 3:22:00 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 11/8/2019 3:15:19 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 11/1/2019 5:22:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/31/2019 4:07:01 PM
Applied DNA Sciences Announces 1-For-40 Reverse Stock Split Business Wire - 10/31/2019 1:00:00 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 10/25/2019 4:28:35 PM
Applied DNA Receives Notice of Allowance on Patent Protecting its CertainT® Platform in Cellulosic Fibers and Materials Business Wire - 10/22/2019 8:30:00 AM
Applied DNA Partners with Molecular Isotope Technologies to Elevate CertainT® for Brand Assurance and Provenance Business Wire - 10/16/2019 5:30:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 10/8/2019 4:02:30 PM
Molecular Tagging of Pharmaceutical Excipients Utilizing Applied DNA’s Technology Published in Peer-Reviewed Journal Business Wire - 10/4/2019 5:00:00 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 10/3/2019 4:03:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/3/2019 6:32:21 AM
Applied DNA Receives Extension from Nasdaq Business Wire - 10/3/2019 5:00:00 AM
LineaRx’s iCTC Platform for Isolation of Circulating Tumor Cells Shows Superior Correlation over PSA as a Biomarker in Pros... Business Wire - 10/1/2019 8:30:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 9/26/2019 5:23:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/25/2019 4:03:37 PM
Parkmart   Thursday, 10/03/19 09:55:17 PM
Re: apdn1mill post# 56588
Post # of 57017 
Really, this has all gone on too long.
Even if a reverse split gets the price up to 4 bucks and they get the 2.5 million in equity....
It will only take another poor quarter to sink right back down.
Investors need a reason from Hayward that makes sense.

No more gobbledy gook

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
© 2019 InvestorsHub.com, Inc.